Clinical Trial Update: SC0191 Plus Chemotherapy in Advanced Ovarian Canceradvanced Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for SC0191 combined with chemotherapy in advanced serous ovarian cancer, currently in Phase 1/Phase 2, sponsor Biocity Biopharmaceutics Co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Serous Ovarian Cancer

Drugs mentioned

• Chemotherapy (chemotherapy)
• SC0191

Snippet

Sponsor: Biocity Biopharmaceutics Co., Ltd. | Conditions: Serous Ovarian Cancer, Advanced Ovarian Cancer | Phase 1, Phase 2 | Status: UNKNOWN